Metraipolis › archive › dc_d2eeadaae9d9

Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies — Europe PMC PMID:42649903

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42649903
DOI
10.3390/cancers18162589
License (as archived)
solo-consultazione
Archived
2026-10-16T20:51:15.546Z
SHA-256 of the archived text
608b9b2b88a4e715651f0f13ee44564043e5cc051f0a79f4e01e184df77edc96
Stable URL of this page
https://metraipolis.com/documento/dc_d2eeadaae9d9

How to cite

Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies — Europe PMC PMID:42649903 — Europe PMC (en), https://europepmc.org/article/MED/42649903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2eeadaae9d9 (Metraipolis archive dc_d2eeadaae9d9, sha256 608b9b2b88a4e715651f0f13ee44564043e5cc051f0a79f4e01e184df77edc96)
BibTeX
@misc{dcd2eeadaae9d9,
  title = {Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies — Europe PMC PMID:42649903},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42649903},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2eeadaae9d9; sha256 608b9b2b88a4e715651f0f13ee44564043e5cc051f0a79f4e01e184df77edc96},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649903. Agents can read the archived copy with the MCP tool read_document.